CLARENCE, N.Y., Dec. 1, 2000 (PRIMEZONE) -- Wilson Greatbatch Technologies, Inc. (NYSE:GB) (the "Company") today announced a number of major organizational changes with the establishment of the Office of the Chairman and a new Corporate Development Department, moves which can be expected to seize growth opportunities made possible by the successful Sept. 29, 2000 IPO.
In announcing the organizational changes, Edward F. Voboril, Chairman of the Board, President and CEO stated, "Wilson Greatbatch Technologies, Inc. has an outstanding senior leadership team that has adapted rapidly to the dynamics of the public equities market. Our new structural alignment will enable an enhanced focus on business development, operationally driven growth, financial strategies, and regulatory and reporting requirements."
Mr. Voboril also stated that "the members of the Office of the Chairman will directly assist me in addressing these key areas as follows:
-- Larry T. DeAngelo, Senior Vice President, Administration and
Secretary
-- Arthur J. Lalonde, Senior Vice President, Finance
-- Richard W. Mott, Executive Vice President and Chief Operating
Officer
Richard W. Mott, as Executive Vice President and Chief Operating Officer, will now be responsible for all of the Company's medical businesses, as well as Information Technology. This includes Implantable Power Sources, Capacitor Operations, Engineered Components Division, and Greatbatch-Hittman, Inc.
Wilson Greatbatch Technologies, Inc. with operations in New York, Maryland, and Massachusetts, is a leading developer and manufacturer of power sources and other critical components used in implantable medical devices, as well as batteries for demanding commercial applications including space flight and oil exploration.
Note: Additional information about Wilson Greatbatch Technologies, Inc. is also available at http://www.greatbatch.com.